A carregar...
Uridine monophosphate synthetase enables eukaryotic de novo NAD(+) biosynthesis from quinolinic acid
NAD(+) biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD(+) biosynthetic pathways. Here, we report a...
Na minha lista:
Publicado no: | J Biol Chem |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Biochemistry and Molecular Biology
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500784/ https://ncbi.nlm.nih.gov/pubmed/28559281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.C117.795344 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|